Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

Delayed Quote. Delayed Nasdaq - 05/22 04:00:00 pm
65.36 USD   +3.06%
05/06 ANACOR PHARMACE : reports 1Q loss
05/06 ANACOR PHARMACE : Reports First Quarter 2015 Financial Results
05/01 ANACOR PHARMACE : to Present at Upcoming Investor Conferences
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
61.89(c) 62.62(c) 64.01(c) 63.42(c) 65.36(c) Last
529 270 554 251 348 636 448 059 642 333 Volume
-0.77% +1.18% +2.22% -0.92% +3.06% Change
More quotes
Financials ($)
Sales 2015 69,2 M
EBIT 2015 -47,4 M
Net income 2015 -50,0 M
Debt 2015 18,5 M
Yield 2015 -
Sales 2016 116 M
EBIT 2016 -8,21 M
Net income 2016 -10,6 M
Debt 2016 6,79 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 40,3x
EV / Sales 2016 23,9x
Capitalization 2 775 M
More Financials
Company
Anacor Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
05/15 ANACOR PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
05/11 ANACOR PHARMACEUTICALS : Reports 1Q 2015 Financial Results
05/08 ANACOR PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
05/07 ANACOR PHARMACEUTICALS : to Take Part in Upcoming Investor Conferences
05/06 ANACOR PHARMACEUTICALS : reports 1Q loss
05/06 ANACOR PHARMACEUTICALS : Results of Operations and Financial Condition, Financia..
05/06 ANACOR PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
05/01 ANACOR PHARMACEUTICALS : to Present at Upcoming Investor Conferences
More news
Sector news : Biotechnology & Medical Research - NEC
11:28a SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
07:04a BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/06 Anacor Pharmaceuticals' (ANAC) CEO Paul Berns on Q1 2015 Results - Earnings C..
05/06 Anacor Pharmaceuticals (ANAC) Q1 2015 Results - Earnings Call Webcast
05/06 Anacor Pharmaceuticals beats by $0.19, beats on revenue
05/05 Notable earnings after Wednesday's close
04/29 INSIDERINSIGHTS.COM DAILY ROUND UP A : Opk, nxrt, cen, utek


Comments 
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions